Determinants of folic acid use in a multi-ethnic population of pregnant women: A cross-sectional study

Journal of Perinatal Medicine

Volumn 39, Issue 6, 2011, Pages 685-692

  Baraka, Mohamed A ^a   Steurbaut, Stephane ^b   Leemans, Liesbeth ^a   Foulon, Walter ^b   Laubach, Monika ^b   Coomans, Danny ^a   Jansen, Eleonora ^b   Dupont, Alain G ^b  

^a FACULTY OF MEDICINE AND PHARMACY   (Belgium)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Arab women; ethnicity; folic acid; immigration; neural tube defects; pregnancy

Indexed keywords

FOLIC ACID;

ADULT; ARAB; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EDUCATIONAL STATUS; EMPLOYMENT STATUS; ETHNIC DIFFERENCE; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MATERNAL NUTRITION; OBSTETRIC PATIENT; PREGNANCY; PREGNANT WOMAN; PRENATAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; TURKEY (REPUBLIC); VITAMIN SUPPLEMENTATION;

ADOLESCENT; ADULT; ARABS; BELGIUM; CROSS-SECTIONAL STUDIES; EDUCATIONAL STATUS; EMIGRATION AND IMMIGRATION; ETHNIC GROUPS; FEMALE; FOLIC ACID; HUMANS; LOGISTIC MODELS; MIDDLE AGED; NEURAL TUBE DEFECTS; PREGNANCY; PRENATAL CARE; QUESTIONNAIRES; SOCIOECONOMIC FACTORS; TURKEY; YOUNG ADULT;

EID: 80955126674     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/JPM.2011.085     Document Type: Article

References (24)

1. Alevizos AG, Stamatiou KN, Lacroix RE, Natzar MA, Mihas CC, Bovis KD, et al. Dietary intake in immigrant Arabian pregnant women. Saudi Med J. 2006;27:1019-21.
2. Bakker MK, Cornel MC, De Walle HEK. Awareness and periconceptional use of folic acid among non-Western and Western women in the Netherlands following the 1995 publicity campaign. Ned Tijdschr Geneeskd. 2003;147:2426-30.
3. Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H, et al. Prevention of neural-tube defects with folic acid in China. China U.S. collaborative project for neural tube defect prevention. N Engl J Med. 1999;341:1485-90.
4. Brough L, Rees GA, Crawford MA, Dorman EK. Social and ethnic differences in folic acid use during preconception and early pregnancy in the UK: effect on maternal folate status. J Hum Nutr Diet. 2009;22:100-7.
5. Busby A, Abramsky L, Dolk H, Armstrong B, Eurocat folic acid working group. Preventing neural tube defects in Europe: population based study. Br Med J. 2005;330:574-5.
6. Centers for Disease Control and Prevention. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR. 1992H- 14:1-7.
7. Cornel MC, De Smit DJ, De Jong-van den Berg LTW. Folic acid - the scientific debate as a base for public health policy. Reprod Toxicol. 2005;20:411-5.
8. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992;327:1832-5.
9. EUROCAT Working Group. Prevalence of neural tube defects in 20 regions of Europe and the impact of prenatal diagnosis, 1980-1986. J Epidemiol Community Health. 1991;45:52-8.
10. Hassan AS, Al-kharusi BM. Knowledge and use of folic acid among pregnant Arabian women residing in Qatar and Oman. Int J Food Sci Nutr. 2008;59:70-9.
11. Houcher B, Bourouba R, Djabi F, Houcher Z. The prevalence of neural tube defects in Sétif university maternity hospital, Algeria - 3 years review (2004-2006). Pteridines. 2008;19: 12-8.
12. Howell SR, Barnett AG, Underwood MR. The use of preconceptional folic acid as an indicator of uptake of a health message amongst white and Bangladeshi women in Tower Hamlets, east London. Fam Pract. 2001;18:300-3.
13. Lodewyckx K, Peeters G, Spitz B, Blot S, Temmerman M, Weihong Z, et al. National recommendation for prenatal care. A base for a clinical pathway for the follow-up of pregnancies. (in Dutch). Federal health care knowledge centre KCEreports 2004;6A:21. Available from: http://www.kce.fgov.be. Last accessed on: 15 January 2011.
14. McGuire M, Cleary B, Sahm L, Murphy DJ. Prevalence and predictors of preconception folic acid uptake - prospective cohort study in an Irish urban obstetric population. Hum Reprod. 2010;25:535-43.
15. Meijer WM, de Smit DJ, Jurgens RA, de Jong-van den Berg LTW. Pharmacists role in improving awareness about folic acid: a pilot study on the process of introducing an intervention in pharmacy practice. Int J Pharm Pract. 2004;12:29-35.
16. MRC Vitamin study research group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 1991;338:131-7.
17. Oakley GP. The scientific basis for eliminating folic acidpreventable spina bifida: a modern miracle from epidemiology. Ann Epidemiol. 2009;19:226-30.
18. Racape J, De Spiegelaere M, Alexander S, Dramaix M, Buekens P, Haelterman E. High perinatal mortality rate among immigrants in Brussels. Eur J Public Health. 2010;20:536-42.
19. Rosenberg IH. Science-based micronutrient fortification: which nutrients, how much, and how to know? Am J Clin Nutr. 2005;82:279-80.
20. Timmermans S, Jaddoe VWV, Mackenbach JP, Hofman A, Steegers-Theunissen RPM, Steegers EAP. Determinants of folic acid use in early pregnancy in a multi-ethnic urban population in The Netherlands: the Generation R study. Prev Med. 2008;47:427-32.
21. Tuncbilek E, Boduroglo K, Alikasifoglu M. Neural tube defects in Turkey: prevalence distribution and risk factors. Turk J Pediatr. 1999;41:299-305.
22. Van der pal-de Bruin KM, De Walle HEK, De Rover CM, Jeeninga W, Cornel MC, de Jong-van den Berg LTW, et al. Influence of educational level on determinants of folic acid use. Paediatr Perinat Epidemiol. 2003;17:256-63.
23. Van Eijsden M, van der Wal MF, Bonsel GJ. Folic acid knowledge and use in a multi-ethnic pregnancy cohort: the role of language proficiency. Br J Obstet Gynecol. 2006; 113:1446-51.
24. Wasserman CR, Shaw GM, Selvin S, Gould JB, Syme L. Socioeconomic status, neighborhood social conditions, and neural tube defects. Am J Public Health. 1998;88:1674-80.